Surgivance Inc.
New York, NY
- UEI
- JH4EDZ5CQZD5
- CAGE
- 81NC3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 310 E 67th St #291, New York, NY 10065, USA
- Website
- surgivance.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Life Sciences Tools & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Alpenglow Biosciences, Inc. | Seattle, WA | 621511 Medical Laboratories |
| Pensievision, Inc. | San Diego, CA | 513210 Software Publishers |
| Visiopharm A / S | — | 541511 Custom Computer Programming Services |
| Pathware Inc. | Golden, CO | 423450 Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers |
| Quantitative Imaging Systems LLC | Pittsburgh, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Surgivance Inc. is a for-profit corporate entity that manufactures goods. According to its website, the company "revolutionizes cancer care with advanced imaging tech for rapid diagnosis and improved surgical assessments, transforming pathology labs worldwide."
Surgivance Inc. has received several prime federal grant awards from agencies like the National Science Foundation and the National Institutes of Health (NIH) National Cancer Institute to develop advanced surgical pathology devices and imaging technologies. One award from the NSF funded research on "DIGITIZING THE PATHOLOGIST IN THE OPERATING ROOM" to create a digital pathology solution. Two grants from the NIH, totaling nearly $3 million, supported the development of a "confocal-based surgical pathology system" (SPS) that can rapidly image intact tissue specimens with high resolution for cancer diagnosis. This system uses a novel, patented line-scanning, stage-scanning confocal microscope to image standard-sized specimens in just 17 seconds, with plans to integrate AI software for automated mapping and diagnostics. The goal is to enable instant, digital 3D pathology for robust, reproducible, and rapid automated cancer diagnoses, shifting the paradigm from time-consuming traditional histopathology methods.
Quick answers
Is Surgivance Inc. registered in SAM.gov?
Yes. Surgivance Inc.'s SAM.gov registration is active through March 17, 2027.
What is Surgivance Inc.'s most recent federal award?
Surgivance Inc.'s most recent federal grant award is Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple… (R44CA302122), from National Cancer Institute (NIH), on June 18, 2025.
On GovTribe
See Surgivance Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors